Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Clin Dermatol ; 32(6): 715-33, 2014.
Article in English | MEDLINE | ID: mdl-25441464

ABSTRACT

Viral infections affecting the face may cause significant morbidity, cosmetic disfigurement, and psychological distress. The success of therapy needs whole and correct evaluation of the clinical signs and symptoms. Some viruses such as Papillomaviridae, Herpesviridae, and Polyomaviridae primarily infect the facial skin, whereas others affect the face infrequently, as in parapox virus infections. Sometimes, involvement of the face can be a part of more generalized eruption and systemic symptoms in viral infections caused by Todaviridae, Flaviviridae, Arenaviridiae, and Flaviviridae. Clinical diagnosis can be challenging in various viral diseases when they occur in nonendemic geographic areas. The objective of this review was to concentrate on epidemiologic and clinical characteristics of the viral illnesses with facial skin involvement.


Subject(s)
Antiviral Agents/therapeutic use , Facial Dermatoses/epidemiology , Facial Dermatoses/virology , Virus Diseases/epidemiology , Virus Diseases/virology , Esthetics , Facial Dermatoses/drug therapy , Female , Herpesviridae/drug effects , Herpesviridae/isolation & purification , Humans , Incidence , Male , Papillomaviridae/drug effects , Papillomaviridae/isolation & purification , Polyomaviridae/drug effects , Polyomaviridae/isolation & purification , Risk Assessment , Severity of Illness Index , Treatment Outcome , Virus Diseases/drug therapy
2.
J Dermatolog Treat ; 24(1): 70-4, 2013 Feb.
Article in English | MEDLINE | ID: mdl-21923567

ABSTRACT

UNLABELLED: Although erythrasma is a superficial skin infection, there is no consensus on the treatment model of erythrasma. OBJECTIVE: To compare the efficacy of erythromycin, single-dose clarithromycin and topical fusidic acid in the treatment of erythrasma in a double-blind, placebo-controlled, randomized trial. METHODS: Hundred and fifty-one patients over 18 years of age were included in this study. Patients were randomized and divided into five groups. They received clarithromycin, erythromycin, fusidic acid cream, placebo cream or placebo tablets. Patients were evaluated by Wood's light reflection scores and the initial score values and the values on the days of 2, 7 and 14 were compared statistically. RESULTS: According to the mean of Wood's light reflection scores, the efficacy of fusidic acid cream therapy was significantly higher than other therapies. When the efficacy of clarithromycin and erythromycin therapy was compared, clarithromycin therapy was significantly more effective than erythromycin therapy at 48 h. However, there was no statistical difference on the days of 7 and 14. CONCLUSION: Topical fusidic acid proved to be the most effective treatment; however, clarithromycin therapy may be an alternative regimen in the treatment of erythrasma because of its efficiency and better patient's compliance.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Clarithromycin/therapeutic use , Erythrasma/drug therapy , Erythromycin/therapeutic use , Fusidic Acid/therapeutic use , Skin Diseases, Bacterial/drug therapy , Adolescent , Adult , Aged , Double-Blind Method , Female , Humans , Male , Middle Aged , Skin Cream , Treatment Outcome , Young Adult
3.
J Dtsch Dermatol Ges ; 6(2): 130-2, 2008 Feb.
Article in English, German | MEDLINE | ID: mdl-18076662

ABSTRACT

Although basal cell carcinoma is extremely common, it only rarely occurs on the nipple. Men are affected more often than women. Basal cell carcinoma of the nipple-areola complex may be more aggressive as metastases to regional lymph nodes have been reported. We report a basal cell carcinoma of the nipple with features of a fibroepithelioma of Pinkus in a man and review the literature.


Subject(s)
Breast Neoplasms, Male/diagnosis , Carcinoma, Basal Cell/diagnosis , Nipples , Skin Neoplasms/diagnosis , Biopsy , Breast Neoplasms, Male/pathology , Breast Neoplasms, Male/surgery , Carcinoma, Basal Cell/pathology , Carcinoma, Basal Cell/surgery , Diagnosis, Differential , Humans , Male , Mammography , Mastectomy, Simple , Middle Aged , Nipples/pathology , Nipples/surgery , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Ultrasonography, Mammary
4.
Dermatology ; 209(2): 126-31, 2004.
Article in English | MEDLINE | ID: mdl-15316166

ABSTRACT

BACKGROUND: We have earlier found a highly efficient induction of the differentiation of epidermal lineage skin tumors by cyclopamine, a steroidal alkaloid inhibitor of the hedgehog/smoothened signaling, under conditions in which cyclopamine exerted no adverse effect on skin. OBJECTIVE: We aimed to develop a mechanism-based treatment for psoriasis with cyclopamine. METHODS: We subjected psoriatic skin lesions to cyclopamine under conditions similar to those we used for skin tumors and evaluated the responses of lesions clinically and by histopathological/immunohistochemical analyses. RESULTS: All treated lesions in different patients having plaque and guttate forms of psoriasis regressed rapidly. Differentiation of the epidermal cells of lesional skin and disappearances of infiltrating inflammatory cells were evident within a day. Lesions were cleared commonly on days 3-4. Former treatment sites followed up for more than 24 months now show a lack of adverse effects in the long term. CONCLUSION: An effective treatment for psoriasis is described, consistent with intervention in a proximal/key pathogenic event.


Subject(s)
Psoriasis/drug therapy , Psoriasis/pathology , Veratrum Alkaloids/administration & dosage , Administration, Topical , Adult , Biopsy, Needle , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Follow-Up Studies , Humans , Immunohistochemistry , Male , Middle Aged , Prospective Studies , Risk Assessment , Severity of Illness Index , Treatment Outcome
5.
Eur J Dermatol ; 14(2): 96-102, 2004.
Article in English | MEDLINE | ID: mdl-15196999

ABSTRACT

Hedgehog/smoothened signaling is active in a variety of tumors and is also involved in the maintenance of normal stem cells in vivo. We evaluated the possibility of preferential affection of tumor versus normal cells following inhibition of this signaling. We applied a cream preparation of cyclopamine (an inhibitor of the hedgehog/smoothened signaling) onto skin tumors in patients who were scheduled for the excision of these tumors (four basal cell carcinomas and a trichoepithelioma in four unrelated patients). All of the cyclopamine-treated tumors regressed rapidly. Histological and immunohistochemical analyses showed inhibition of the proliferation and highly efficient induction of the differentiation and apoptosis of tumor cells by a non-genotoxic mechanism. No adverse effects were noted and normal skin tissue and putative stem cells that were exposed to cyclopamine together with tumors were well preserved under the conditions we describe. Our findings show selective and highly efficient induction of the differentiation and apoptosis of tumor cells in vivo by transient inhibition of the hedgehog/ smoothened signaling and provide a rational cancer therapy.


Subject(s)
Apoptosis/drug effects , Cell Transformation, Neoplastic/drug effects , Skin Neoplasms/pathology , Veratrum Alkaloids/pharmacology , Aged , Aged, 80 and over , Cell Division/drug effects , Hedgehog Proteins , Humans , Male , Middle Aged , Receptors, G-Protein-Coupled/antagonists & inhibitors , Receptors, G-Protein-Coupled/physiology , Signal Transduction/drug effects , Skin Neoplasms/physiopathology , Smoothened Receptor , Trans-Activators/antagonists & inhibitors , Trans-Activators/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...